Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer

ATEŞ Ö. , BABACAN T. , KERTMEN N. , Sarici F., Cenoli A., AKIN S. , ...Daha Fazla

JOURNAL OF BUON, cilt.21, sa.2, ss.375-381, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 21 Konu: 2
  • Basım Tarihi: 2016
  • Dergi Adı: JOURNAL OF BUON
  • Sayfa Sayıları: ss.375-381


Purpose: Eribulin is a non-taxane microtubule inhibitor, which can be used after anthracycline and taxane treatment in patients with metastatic breast cancer (MBC). The purpose of this study was to investigate the efficacy and safety of eribulin monotherapy in heavily pretreated MBC patients.